Pacific Edge Limited (NZX: PEB) is hosting an event today in Auckland, with two internationally renowned urologists presenting on the performance and commercial use of Cxbladder in their USA and New Zealand clinical settings respectively.  Videos of their presentations can be viewed HERE

Dr Sia Daneshmand: Associate Professor of Urology and Director of Urologic Oncology, Keck Medical Centre - University of Southern California.  Dr Daneshmand recently presented at the prestigious South East Asian Urofair 2019 conference in Singapore, on Urine Biomarkers and the Detection of Urothelial Carcinoma.

Dr Madhusudan Koya: Clinical Director of Urology at Waitemata DHB and President of the New Zealand section of the Urological Society of Australia and New Zealand. Dr Koya also presented at Urofair 2019 and will be discussing the real world use of Cxbladder and its clinical utility in New Zealand.

Dr Daneshmand’s and Dr Koya’s presentations demonstrate the accumulated clinical evidence underpinning the adoption of Cxbladder, its commercial use and the benefits for patients, physicians, healthcare funders and providers alike.